Seeking a New Paradigm for Alzheimer’s Disease: Considering the Roles of Inflammation, Blood-Brain Barrier Dysfunction, and Prion Disease
There is no effective etiologic treatment for Alzheimer’s disease, nor is there a prophylactic medication which delays or prevents its onset. The lack of an accurate paradigm is undoubtedly related to the lack of effective means of prophylaxis and treatment. The current paradigm of beta amyloid in A...
Main Authors: | Mark E. McCaulley, Kira A. Grush |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | International Journal of Alzheimer's Disease |
Online Access: | http://dx.doi.org/10.1155/2017/2438901 |
Similar Items
-
Alzheimer’s Disease: Exploring the Role of Inflammation and Implications for Treatment
by: Mark E. McCaulley, et al.
Published: (2015-01-01) -
Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease
by: Yu Yamazaki, et al.
Published: (2017-09-01) -
The blood-brain barrier in Alzheimer's disease
by: Elena Zenaro, et al.
Published: (2017-11-01) -
Relationship Between Amyloid-β Deposition and Blood–Brain Barrier Dysfunction in Alzheimer’s Disease
by: Dong Wang, et al.
Published: (2021-07-01) -
Blood–Brain Barrier Dysfunction in a 3D In Vitro Model of Alzheimer's Disease
by: Yoojin Shin, et al.
Published: (2019-10-01)